Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings

UNC Libraries(2020)10.17615/nneb-s785Source: DataRank Database

Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: greenTopics (36)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Joseph J. Eron ORCID,Mina C. Hosseinipour ORCID,Ravindra K. Gupta ORCID,Jean B Nachega ORCID,Gert U. van Zyl ORCID

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4300642646

Wellcome Trust

Grant: 087537

Southern Africa Consortium for Research Excellence (SACORE)

Wellcome Trust

Grant: 081772

The evolution and impact of HIV-1 resistance following the public health rollout of antiretroviral therapy in Africa.

FWCI

0.00

Citation Percentile

0.2%

greenLicense: http://rightsstatements.org/vocab/InC/1.0/

repositoryhttps://doi.org/10.17615/nneb-s785

https://doi.org/10.1093/infdis/jit107

https://europepmc.org/articles/pmc3708738?pdf=render

https://dx.doi.org/10.17615/nneb-s785

https://pubmed.ncbi.nlm.nih.gov/23687289

Fields of Study

HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV Research and Treatment03 medical and health sciences0302 clinical medicine

Keywords

Antiretroviral therapyAntiretroviral drugHuman immunodeficiency virus (HIV)HIV drug resistanceDrug resistanceDrugResource (disambiguation)VirologyFirst lineResistance (ecology)MedicineViral loadComputer scienceBiologyPharmacologyInternal medicineGeneticsEcologyMutation, MissenseHIV InfectionsHIV Protease InhibitorsAnti-Retroviral AgentsDrug Resistance, ViralMutationHIV-1Health ResourcesHumansRNA, ViralReverse Transcriptase InhibitorsDrug Therapy, CombinationTreatment Failure

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being